Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (nsaid) treatment in rheumatoid arthritis

Rheumatology

Volumn 30, Issue 1, 1991, Pages 16-20

  Jones, S T M ^a   Clague, R B ^b   Eldridge, J ^b   Jones, D M ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antibodies; Dyspepsia; Helicobacter pylori; Non steroidal anti inflammatory drugs; Peptic ulcer disease; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BACTERIUM ANTIBODY; CHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; DIAGNOSIS; DRUG THERAPY; DYSPEPSIA; ETIOLOGY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, BACTERIAL; ARTHRITIS, RHEUMATOID; COMPLEMENT FIXATION TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORECASTING; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; MIDDLE AGE;

EID: 0025736731     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/30.1.16     Document Type: Article

References (36)

1. Collier DSU, Pain JA. Nonsteroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985;26:359-63.
2. Duggan JM, Dobson AJ, Johnson H, Fahey P. Peptic ulcers and nonsteroidal anti-inflammatory drugs. Gut 1986;27:929-33.
3. Somerville K, Faulkner G, Longman M. Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;i:462-4.
4. Scander MP, Ryan FP. Non-steroidal anti-inflammatory drugs and pain-free peptic ulceration in the elderly. Br Med J 1988;297:833-4.
5. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987;28:527-32.
6. Walt R, Katschinski B, Logan R, et al. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986;i:489-92.
7. Matthewson K, Pugh S, Northfield TC. Which peptic ulcer patients bleed? Gut 1988;29:70-4.
8. Jorde R, Burhol PG. Asymptomatic peptic ulcer disease—a review. Scand J Gastroenterol 1987; 22:129-34.
9. Malone DE, McCormick PA, Daly L, et al. Peptic ulcer in rheumatoid arthritis—intrinsic or related to drug therapy? Br J Rheumatol 1986;25:342-4.
10. Roth SH, Bennett RE. Nonsteroidal-anti-inflammatory drug gastropathy—recognition and response. Arch Int Med 1987;147:2093-100.
11. Caruso I, Porro GB. Gastroscopie evaluation of anti-inflammatory agents. Br Med J 1980;280:75-7.
12. Farah D, Sturrock RD, Russell RI. Peptic ulcer in rheumatoid arthritis. Ann Rheum Dis 1988;47:478-80.
13. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-15.
14. Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol 1986;39:353-65.
15. Dooley CP, Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med 1988; 108:70-9.
16. Upadhyay R, Howatson A, McKinlay A, Danesh BJZ, Sturrock RD, Russell RI. Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking non-steroidal anti-inflammatory drugs. Br J Rheumatol 1988;27:113-16.
17. Heatley RV, Rathbone BJ. Dyspepsia: a dilemma for doctors. Lancet 1987;i:779-82.
18. Jones DM, Eldridge J, Fox AJ, Sethi P, Whorwhell PJ. Antibody to the gastric campylobacter-like organism (‘Campylobacterpyloridis’)—clinical correlations and distribution in the normal population. J Med Microbiol 1986;22:57-62.
19. Goughlan G, Humphries H, Dooley C, et al. Campylobacter pyloridii and recurrence of duodenal ulcer—a 12 month follow-up study. Lancet 1987;ii: 1109-11.
20. Rathbone BJ, Wyatt JI, Worsley BW, et al. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 1986;27:642-7.
21. Jones DM, Lessels AM, Eldridge J. Campylobacter like organism on the gastric mucosa: culture, histological and serological studies. J Clin Pathol 1984;37:1002-6.
22. Sethi P, Banerjee AK, Jones DM, Eldridge J, Hollanders D. Gastritis and campylobacter-like organisms in patients without peptic ulcer. Postgrad Med J 1987;63:543-5.
23. Lanza FL, Roger GL, Nelson RS, Chen TT, Seckman CE, Rack MF. The effects of Ibuprofen, indo-methacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers. Dig Dis Sci 1979;24:823-8.
24. Isenberg JI, Selling JA, Hogan DL, Koss MA. Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer. N Engl J Med 1987;316:374-9.
25. Taylor IL, Calam J, Rotter JI, et al. Family studies of hypergastrinaemic duodenal ulcer. Ann Intern Med 1981;95:451-5.
26. Slomiany BL, Bilski J, Sarosiek J, Murty VLN. Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 1987;144:307-14.
27. Tompkins DS, West AP. Campylobacter pylori, acid, and bile. J Clin Pathol 1987;40:1387.
28. Chen XG, Correa P, Offerhaus J, Rodrigues E, Janney F. Ultrastructure of the gastric mucosa harbouring Campylobacter-like organisms. Am J Clin Pathol 1986;86:575-82.
29. Spira WM, Gilman RH. Rapid identification of pyloric Campylobacter in Peruvians with gastritis. Dig Dis Sci 1986;31:1089-94.
30. Ross IN, Bahari HMM, Turnberg LA. The pH gradient across mucus adherent to rat fundic mucosa in vivo and the effect of potentially damaging agents. Gastroenterology 1981;81:713-18.
31. Aly A, Selling JA, Hogan DL, Isenberg JI, Koss MA, Johanssen C. Gastric and duodenal PGE2 in humans: effect of luminal acidification and indomethacin. Gastroenterology 1985;88:1305.
32. Tarnawski A, Hollander D, Stachura J. Prostaglandin protection of gastric mucosa accompanied by alcohol injury—role of the mucosal proliferative zone. Gastroenterology 1985;88:334-52.
33. Collins AJ, Davies J, Dixon ASJ. A prospective endoscopic study of the effect of Orudis and Oruvail on the upper gastrointestinal tract, in patients with osteoarthritis. Br J Rheumatol 1988;27:106-9.
34. Larkai EN, Smith JL, Lidsky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritis patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 1153-7.
35. Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol—a multicentre, double-blind, placebo controlled trial. Lancet 1988;ii:1277-80.
36. Marshall BJ, Warren JR, Blincow ED, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;ii: 1437-42.